These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24917853)

  • 1. The roles of lipids and nucleic acids in HIV-1 assembly.
    Alfadhli A; Barklis E
    Front Microbiol; 2014; 5():253. PubMed ID: 24917853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
    Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.
    Inlora J; Collins DR; Trubin ME; Chung JY; Ono A
    mBio; 2014 Dec; 5(6):e02202. PubMed ID: 25491356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
    Thornhill D; Olety B; Ono A
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranes.
    Kempf N; Postupalenko V; Bora S; Didier P; Arntz Y; de Rocquigny H; Mély Y
    J Virol; 2015 Feb; 89(3):1756-67. PubMed ID: 25410868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate.
    Alfadhli A; Barklis RL; Barklis E
    Virology; 2009 May; 387(2):466-72. PubMed ID: 19327811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.
    Alfadhli A; Still A; Barklis E
    J Virol; 2009 Dec; 83(23):12196-203. PubMed ID: 19776118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 matrix protein binding to RNA.
    Alfadhli A; McNett H; Tsagli S; Bächinger HP; Peyton DH; Barklis E
    J Mol Biol; 2011 Jul; 410(4):653-66. PubMed ID: 21762806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
    Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
    J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The matrix domain of the Gag protein from avian sarcoma virus contains a PI(4,5)P
    Watanabe SM; Medina GN; Eastep GN; Ghanam RH; Vlach J; Saad JS; Carter CA
    J Biol Chem; 2018 Dec; 293(49):18841-18853. PubMed ID: 30309982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between HIV-1 Gag Multimerization and Membrane Binding.
    Sumner C; Ono A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.
    Dick RA; Barros M; Jin D; Lösche M; Vogt VM
    J Virol; 2015 Dec; 90(5):2473-85. PubMed ID: 26676779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging.
    Wang H; Norris KM; Mansky LM
    J Virol; 2003 Sep; 77(17):9431-8. PubMed ID: 12915558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of small molecule ligands targeting the HIV-1 matrix protein-RNA binding site.
    Alfadhli A; McNett H; Eccles J; Tsagli S; Noviello C; Sloan R; López CS; Peyton DH; Barklis E
    J Biol Chem; 2013 Jan; 288(1):666-76. PubMed ID: 23135280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer.
    Alfadhli A; Huseby D; Kapit E; Colman D; Barklis E
    J Virol; 2007 Feb; 81(3):1472-8. PubMed ID: 17108052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.
    Mercredi PY; Bucca N; Loeliger B; Gaines CR; Mehta M; Bhargava P; Tedbury PR; Charlier L; Floquet N; Muriaux D; Favard C; Sanders CR; Freed EO; Marchant J; Summers MF
    J Mol Biol; 2016 Apr; 428(8):1637-55. PubMed ID: 26992353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
    Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
    J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.
    Robinson BA; Reed JC; Geary CD; Swain JV; Lingappa JR
    J Virol; 2014 May; 88(10):5718-41. PubMed ID: 24623418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.
    Barklis E; Staubus AO; Mack A; Harper L; Barklis RL; Alfadhli A
    Virology; 2018 May; 518():264-271. PubMed ID: 29549788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.
    Pachulska-Wieczorek K; Błaszczyk L; Biesiada M; Adamiak RW; Purzycka KJ
    Retrovirology; 2016 Mar; 13():18. PubMed ID: 26987314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.